The POMT1 gene helps make a protein that adds a small sugar tag to other proteins, a step that supports normal muscle, brain, and eye development. When this gene does not work well, those tissues may not form or function as expected. Pathogenic variants in the POMT1 gene can lead to a group of inherited conditions that often include muscle weakness, delayed development, and sometimes changes in the brain or eyes. Effects vary widely from person to person.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or for guiding processes throughout the body. Some genes carry the code for building proteins, the active parts of cells. Others mainly regulate when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. More on this topic is available in the LearnHub.
Overview
POMT1Gene function
What if the gene works
The POMT1 gene helps cells attach a sugar to certain proteins. This step supports normal muscle function and healthy development of the brain and eyes.
Risk
What if the gene does not work
Variants that reduce function of the POMT1 gene can lead to muscle conditions ranging from milder weakness around the shoulders and hips to congenital muscular dystrophy. More severe variants may also affect brain development and eyes, with symptoms starting earlier.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently tailored specifically to pathogenic variants in the POMT1 gene, so care focuses on managing symptoms and complications. The POMT1 gene is being studied in early-stage research on related inherited muscle conditions, including gene-based approaches.
Conditions associated with POMT1
Gene function
What if the gene works
Some proteins need a small sugar tag before they can do their jobs well. The POMT1 gene starts one of these tagging steps, helping certain proteins be prepared and connected correctly at the cell surface. This is part of what the POMT1 gene does in the body to keep cells organized and attached to nearby support structures.
The POMT1 gene starts a process called O-mannosylation, which adds a mannose sugar to selected proteins. This first tag is placed while proteins are being prepared inside the endoplasmic reticulum (the cell’s protein-processing area).
POMT1 works together with the protein made from the POMT2 gene to carry out this step. This pairing helps the right proteins receive their sugar tag during early processing in the cell.
One important target is alpha-dystroglycan, a protein that helps cells hold on to their surroundings. By helping prepare this protein, the POMT1 gene supports steady links between cells and the supportive material around them.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human variation, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many have no noticeable effects at all and simply represent natural genetic diversity. At times, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
POMT1 gene variants can reduce or abolish the activity of an enzyme that begins adding sugar chains to a surface protein called alpha-dystroglycan. Milder variants may leave some activity, while more severe variants can stop the process almost completely. This can change how well cells anchor and send signals, and in conditions linked to the POMT1 gene it may influence how early symptoms appear and how broad the effects are.
How variants are linked to conditions
Pathogenic variants in the POMT1 gene cause a group of inherited conditions that affect muscle strength and development, including POMT1-related muscular dystrophy, Walker-Warburg syndrome, and some forms of limb-girdle muscular dystrophy. Depending on the variant, people may also have developmental delay, intellectual disability, eye changes, or brain differences seen on scans. Severity varies widely, from symptoms starting at birth to milder weakness appearing later.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal part of human biology. Most do not have a direct effect on health and instead reflect the natural diversity seen among people. For many genes, carrying a variant connected with a condition suggests a possible association, not a definite diagnosis, especially when more than one gene and environmental influences are involved. Still, in certain situations, one specific, well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For POMT1, risk is mainly shaped by inheritance rather than lifestyle. A child is at higher risk only if both biological parents carry a harmful POMT1 change, so family history and having parents who are related by blood can raise the chance that the same change is passed on.
Inheritance of POMT1 variants
POMT1-related conditions are inherited in an autosomal recessive pattern. This means a child inherits one POMT1 variant from each parent, and both parents are usually healthy carriers. When both parents carry a variant in the POMT1 gene, each pregnancy has a 25% chance of the child being affected, a 50% chance of the child being a carrier, and a 25% chance of the child inheriting neither variant. In practical terms, how variants of the POMT1 gene are inherited depends on both parents passing on the altered copy.
What does my POMT1 result mean for my family?
For POMT1, family implications are usually those of a recessive inherited condition. Parents of an affected child are often healthy carriers, and brothers and sisters may also be affected or be carriers even if they seem well. Other close relatives may also carry the same gene change, so the result can matter for family planning across the wider family.
Genetic information
Genetic testing
How you find out about variants
POMT1 genetic testing looks for changes in the POMT1 gene using a blood sample, saliva, or a cheek swab. A lab reads the gene’s DNA code to check for variants that may help explain muscle weakness, developmental differences, or related findings, and results can show a disease causing variant, a benign variant, or an unclear result.
When should I consider getting a genetic test?
Genetic testing for the POMT1 gene may be considered when a baby or child has severe muscle weakness, low muscle tone, delayed development, or brain and eye changes that suggest an inherited muscle condition. It can also help when a close relative has a POMT1-related condition or both parents are known carriers.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and on the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication may work well for one person, seem weaker in another, or cause more side effects in someone else. These differences are common and are one part of why treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. It studies patterns linking genes and drugs to better explain why the same treatment may work differently from one person to another. For many medications, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the POMT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in medication response, so questions about medicines, side effects, or changes in your health are best discussed with your doctor.
History
POMT1 entered medical genetics through work on a group of inherited conditions affecting muscle, brain, and sometimes eye development. In the early 2000s, researchers identified variants in the POMT1 gene in people with Walker Warburg syndrome and related conditions, helping connect these illnesses to a shared biological pathway. From these first observations, research expanded steadily. Scientists then recognized that changes in the POMT1 gene could be linked to a spectrum of severity, from very early and widespread effects to milder forms of muscular dystrophy. This discovery helped shape the broader concept of dystroglycan related conditions, a major step in understanding this area of neuromuscular disease.